No studies have yet investigated molecular markers of other pathomechanisms through which ABCA7 could be involved in AD (e.g. lipid metabolism and immune-related endophenotypes) in the brain, CSF, and/or plasma. Here, ABCA7 is linked to Alzheimer disease.